This bill matters because it addresses a common frustration many people face: not knowing the cost of a prescription drug until they are already at the pharmacy or have committed to a treatment plan. By requiring list prices to be shown in TV ads, it aims to give consumers more financial transparency right from the start. This could empower patients to have more informed discussions with their doctors about the affordability of different treatment options, potentially leading to more cost-effective choices or the consideration of generic alternatives.
If this bill becomes law, consumers could weigh the cost of a drug they see advertised against its perceived benefits before making healthcare decisions, which is not easily done currently. If it does not become law, the current practice of pharmaceutical companies advertising drugs without clear pricing information would continue, leaving many people without crucial cost details when considering new medications. This bill represents an effort to increase price transparency in the healthcare market, connecting drug promotion with cost information.
KEY PROVISIONS
4AI-extracted
PROVISION 01
Requires direct-to-consumer television advertisements for certain prescription drugs and biological products to include a truthful and not misleading textual statement of their list price.
Provides consumers with upfront cost information for drugs advertised on TV, promoting greater transparency.
PROVISION 02
Mandates the Secretary of Health and Human Services, through the Administrator of the Centers for Medicare & Medicaid Services (CMS), to create specific regulations within one year of the bill's enactment.
Ensures timely development of detailed rules for implementation and enforcement of the new advertising requirements.
PROVISION 03
Specifies that the price shown in advertisements must be the 'list price' for a typical 30-day regimen or course of treatment, as determined quarterly.
Defines the specific type of price information to be disclosed, aiming for consistency and relevance to consumer drug usage.
PROVISION 04
Directs CMS to determine whether these regulations should apply to other forms of advertising, the exact format of the price statements, appropriate enforcement mechanisms, and if other price details should be included.
Gives the agency flexibility to adapt the rules and potentially expand the scope of pricing transparency beyond TV ads and define penalties.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill matters because it addresses a common frustration many people face: not knowing the cost of a prescription drug until they are already at the pharmacy or have committed to a treatment plan. By requiring list prices to be shown in TV ads, it aims to give consumers more financial transparency right from the start. This could empower patients to have more informed discussions with their doctors about the affordability of different treatment options, potentially leading to more cost-effective choices or the consideration of generic alternatives.
If this bill becomes law, consumers could weigh the cost of a drug they see advertised against its perceived benefits before making healthcare decisions, which is not easily done currently. If it does not become law, the current practice of pharmaceutical companies advertising drugs without clear pricing information would continue, leaving many people without crucial cost details when considering new medications. This bill represents an effort to increase price transparency in the healthcare market, connecting drug promotion with cost information.
KEY PROVISIONS
AI-extracted
high
Requires direct-to-consumer television advertisements for certain prescription drugs and biological products to include a truthful and not misleading textual statement of their list price.
Provides consumers with upfront cost information for drugs advertised on TV, promoting greater transparency.
high
Mandates the Secretary of Health and Human Services, through the Administrator of the Centers for Medicare & Medicaid Services (CMS), to create specific regulations within one year of the bill's enactment.
Ensures timely development of detailed rules for implementation and enforcement of the new advertising requirements.
med
Specifies that the price shown in advertisements must be the 'list price' for a typical 30-day regimen or course of treatment, as determined quarterly.
Defines the specific type of price information to be disclosed, aiming for consistency and relevance to consumer drug usage.
med
Directs CMS to determine whether these regulations should apply to other forms of advertising, the exact format of the price statements, appropriate enforcement mechanisms, and if other price details should be included.
Gives the agency flexibility to adapt the rules and potentially expand the scope of pricing transparency beyond TV ads and define penalties.
Not later than one year after the date of the enactment of this Act
The Secretary of Health and Human Services, through the CMS Administrator, shall promulgate regulations for prescription drug advertising.
GLOSSARY
AI-written
Direct-to-consumer advertisement
An advertisement that promotes a product, such as a prescription drug, directly to the general public, rather than to healthcare professionals.
Biological product
A medical product that is produced from living organisms or contains components of living organisms, such as vaccines, blood products, or gene therapies.
List price
The official, publicly available price of a prescription drug before any discounts, rebates, or insurance coverage are applied. It is often not the final out-of-pocket cost for a patient.
Centers for Medicare & Medicaid Services (CMS)
A federal agency within the U.S. Department of Health and Human Services that administers the Medicare program and works with states to administer Medicaid, among other healthcare programs.
Promulgate regulations
The process by which a government agency creates and officially publishes new rules that have the force of law.
Title XVIII of the Social Security Act
Refers to the part of the Social Security Act that established the Medicare program, which provides health insurance for Americans aged 65 or older, younger people with certain disabilities, and people with End-Stage Renal Disease.
ACTION TIMELINE
2 EVENTS
JUL 22, 25
Introduced in House
INTROREFERRAL
JUL 22, 25
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Refers to the part of the Social Security Act that established the Medicaid program, which provides health coverage to millions of Americans, including eligible low-income adults, children, pregnant women, elderly adults, and people with disabilities.
